|
|
Blood, 15 September 2007, Vol. 110, No. 6, pp. 2197-2200.
Prepublished online as a Blood First Edition Paper on May 23, 2007; DOI 10.1182/blood-2007-04-083162.
Previous Article | Table of Contents | Next Article 
STEM CELLS IN HEMATOLOGY
Brief Report
Human multipotent mesenchymal stromal cells inhibit proliferation of PBMCs independently of IFN R1 signaling and IDO expression
Friederike Gieseke1,
Burkhardt Schütt2,
Susanne Viebahn1,
Ewa Koscielniak3,
Wilhelm Friedrich4,
Rupert Handgretinger1, and
Ingo Müller1
1 University Children's Hospital, Department of General Pediatrics, Hematology and Oncology, Tübingen;
2 University Children's Hospital, Division of Pediatric Endocrinology, Tübingen;
3 Olga-Hospital, Stuttgart;
4 University Children's Hospital Ulm, Ulm, Germany
Multipotent mesenchymal stromal cells (MSCs) inhibit proliferation, helper, and effector functions in most if not all peripheral blood mononuclear cell (PBMC) subpopulations in vitro. The molecular mechanism is widely thought to imply tryptophan degradation by the interferon- (IFN )–induced expression of indoleamine 2,3-dioxygenase (IDO). However, IDO inhibitors were not able to restore proliferation of PBMCs in each case. Moreover, human MSCs with an IFN receptor 1 (R1) defect inhibited proliferation of HLA-mismatched PBMCs to a similar extent as control MSCs. In contrast to healthy MSCs, IFN R1-deficient MSCs showed no detectable mRNA for IDO—neither in the absence nor in the presence of recombinant human IFN , nor in coculture with HLA-mismatched PBMCs. Based on gene expression profiling, we were able to show that insulin-like growth factor (IGF)–binding proteins contribute to the inhibitory mechanism of MSCs. Taken together, human MSCs exert important immunomodulatory functions in the absence of IFN R1 signaling and IDO, partially accounted for by IGF-binding proteins.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Z. Selmani, A. Naji, I. Zidi, B. Favier, E. Gaiffe, L. Obert, C. Borg, P. Saas, P. Tiberghien, N. Rouas-Freiss, et al.
Human Leukocyte Antigen-G5 Secretion by Human Mesenchymal Stem Cells Is Required to Suppress T Lymphocyte and Natural Killer Function and to Induce CD4+CD25highFOXP3+ Regulatory T Cells
Stem Cells,
January 1, 2008;
26(1):
212 - 222.
[Abstract]
[Full Text]
[PDF]
|
 |
|
| |